Lv11
40 积分 2023-08-03 加入
Structural rewiring of IL-7R dimerization by an oncogenic transmembrane mutation can be reversed by rational design
1小时前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
2天前
已完结
ENHANCING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR PAEDIATRIC SARCOMA THROUGH CAR T ENGINEERING AND TUMOUR MICROENVIRONMENT REWIRING
2天前
求助中
Pooled screening for CAR function identifies novel IL-13Rα2-targeted CARs for treatment of glioblastoma
8天前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
17天前
已完结
Rational design of TGFbRII dominant negative armored GPC3 CAR-T cells for the treatment of hepatocellular carcinoma
1个月前
已关闭
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein
1个月前
已完结
CAR-T cell therapy in hepatocellular carcinoma: from mechanistic insights to clinical translation
1个月前
已完结
Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: A comprehensive review
1个月前
已完结
Serial Killing Assay Using Longitudinal Impedance-Based Tumor Cell Viability Measurement - A Useful Method to Assess T Cell Performance
1个月前
已完结
皖公网安备34019202002308
